Magnetic barcode assay for genetic detection of pathogens

Nature Communications

Volumn 4, Issue , 2013, Pages

  Liong, Monty ^a   Hoang, Anh N ^a   Chung, Jaehoon ^a   Gural, Nil ^a   Ford, Christopher B ^b   Min, Changwook ^a   Shah, Rupal R ^b   Ahmad, Rushdy ^c   Fernandez Suarez, Marta ^a,b,e   Fortune, Sarah M ^b   Toner, Mehmet ^a   Lee, Hakho ^a   Weissleder, Ralph ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Daktari Diagnostics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; NUCLEIC ACID; BACTERIAL DNA;

BACTERIUM; DRUG RESISTANCE; GENE EXPRESSION; GENETIC ANALYSIS; NUCLEIC ACID; PATHOGEN; PUBLIC HEALTH; TUBERCULOSIS;

ARTICLE; ASSAY; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; GENE IDENTIFICATION; GENE SEQUENCE; MAGNETIC BARCODE ASSAY; MYCOBACTERIUM TUBERCULOSIS; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM; BACTERIAL GENOME; DNA BARCODING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MAGNETISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PROCEDURES;

BASE SEQUENCE; DNA BARCODING, TAXONOMIC; DNA, BACTERIAL; GENOME, BACTERIAL; HUMANS; MAGNETICS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY;

EID: 84877752883     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2745     Document Type: Article

References (41)

1. Gazdar, A. F. Personalized medicine and inhibition of EGFR signaling in lung cancer. N. Engl. J. Med. 361, 1018-1020 (2009).
2. Musser, J. M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8, 496-514 (1995).
3. Easley, C. J. K. & Karlinsey, J. M. et al. A fully integrated microfluidic genetic analysis system with sample-in-answer-out capability. Proc. Natl Acad. Sci. USA 103, 19272-19277 (2006). (Pubitemid 46026023)
4. Kaigala, G. V. et al. Automated screening using microfluidic chip-based PCR and product detection to assess risk of BK virus-associated nephropathy in renal transplant recipients. Electrophoresis 27, 3753-3763 (2006).
5. WHO. Global tuberculosis control: WHO Report 2012 (WHO, Geneva, 2012).
6. Koul, A., Arnoult, E., Lounis, N., Guillemont, J. & Andries, K. The challenge of new drug discovery for tuberculosis. Nature 469, 483-490 (2011).
7. Halse, T. A. et al. Combined real-Time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J. Clin. Microbiol. 48, 1182-1188 (2010).
8. Lonnroth, K., Thuong, L. M., Linh, P. D. & Diwan, V. K. Delay and discontinuity-a survey of TB patients search of a diagnosis in a diversified health care system. Int. J. Tuberc. Lung Dis. 3, 992-1000 (1999).
9. Storla, D. G., Yimer, S. & Bjune, G. A. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Pub. Health 8, 15 (2008).
10. Keshavjee, S. & Farmer, P. E. Tuberculosis, drug resistance, and the history of modern medicine. N. Engl. J. Med. 367, 931-936 (2012).
11. Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E. & Källeniu, G. Tuberculosis and HIV co-infection. PLoS Pathog. 8, e1002464 (2012).
12. McNerney, R. & Daley, P. Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat. Rev. Micro. 9, 204-213 (2011).
13. O'Sullivan, C. E., Miller, D. R., Schneider, P. S. & Roberts, G. D. Evaluation of Gen-Probe amplified Mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory. J. Clin. Microbiol. 40, 1723-1727 (2002). (Pubitemid 34493148)
14. Barnard, M., Albert, H., Coetzee, G., O'Brien, R. & Bosman, M. E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177, 787-792 (2008). (Pubitemid 351490566)
15. Banada, P. P. et al. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J. Clin. Microbiol. 48, 3551-3557 (2010).
16. Haun, J. B. et al. Micro-NMR for rapid molecular analysis of human tumor samples. Sci. Transl. Med. 3, 71ra16 (2011).
17. Issadore, D. et al. Miniature magnetic resonance system for point-of-care diagnostics. Lab Chip 11, 2282-2287 (2011).
18. Lee, H., Yoon, T.-J. & Weissleder, R. Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. Angew. Chem. Int. Ed. 48, 5657-5660 (2009).
19. Manganelli, R., Dubnau, E., Tyagi, S., Kramer, F. R. & Smith, I. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol. Microbiol. 31, 715-724 (1999). (Pubitemid 29046111)
20. Muñoz-Elías, E. J. et al. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect. Immun. 73, 546-551 (2005). (Pubitemid 40041149)
21. Deng, H. et al. Gold nanoparticles with asymmetric polymerase chain reaction for colorimetric detection of DNA sequence. Anal. Chem. 84, 1253-1258 (2012).
22. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415 (2003). (Pubitemid 37442169)
23. Palomino, J. C., Martin, A., Von Groll, A. & Portaels, F. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. J. Microbiol. Meth. 75, 161-166 (2008).
24. Schluger, N. W. & Rom, W. N. Current approaches to the diagnosis of active pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 149, 264-267 (1994). (Pubitemid 24066130)
25. Diedrich, C. R. et al. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS One 5, e9611 (2010).
26. Pathak, S., Wentzel-Larsen, T. & Åsjö, B. Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages. Infect. Immun. 78, 4022-4032 (2010).
27. Morgan, M., Kalantri, S., Flores, L. & Pa, M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 5, 62-74 (2005).
28. Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944-1946 (2006). (Pubitemid 43993719)
29. Liong, M., Tassa, C., Shaw, S. Y., Lee, H. & Weissleder, R. Multiplexed magnetic labelling amplification using oligonucleotide hybridization. Adv. Mater. 23, H254-H257 (2011).
30. Ford, C. B. et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43, 482-486 (2011).
31. Dressman, D., Yan, H., Traverso, G., Kinzler, K. W. & Vogelstein, B. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc. Natl. Acad. Sci. USA. 100, 8817-8822 (2003). (Pubitemid 36899181)
32. Dufort, S., Richard, M.-J., Lantuejoul, S. & de Fraipont, F. Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC. J. Exp. Clin. Cancer Res. 30, 57-63 (2011).
33. Hill, H. D. & Mirkin, C. A. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat. Protocols 1, 324-336 (2006).
34. Goddard, G. et al. High-resolution spectral analysis of individual SERS-active nanoparticles in flow. J. Am. Chem. Soc. 132, 6081-6090 (2010).
35. Aldous, W. K., Pounder, J. I., Cloud, J. L. & Woods, G. L. Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR. J. Clin. Microbiol. 43, 2471-2473 (2005). (Pubitemid 40656270)
36. Di Carlo, D., Irimia, D., Tompkins, R. G. & Toner, M. Continuous inertial focusing, ordering, and separation of particles in microchannels. Proc. Natl. Acad. Sci. USA 104, 18892-18897 (2007).
37. Fang, X. et al. A portable and integrated nucleic acid amplification microfluidic chip for identifying bacteria. Lab Chip 12, 1495-1499 (2012).
38. Zou, Y., Liu, Y., Wu, X. & Shell, S. M. Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J. Cell. Physiol. 208, 267-273 (2006). (Pubitemid 43993416)
39. Xia, Y. & Whitesides, G. M. Soft lithography. Angew. Chem. Int. Ed. 37, 550-575 (1998).
40. Weibel, D. B. et al. Torque-actuated valves for microfluidics. Anal. Chem. 77, 4726-4733 (2005). (Pubitemid 41076660)
41. Pittet, M. J., Swirski, F. K., Reynolds, F., Josephson, L. & Weissleder, R. Labelling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. Nat. Protocols 1, 73-79 (2006).